Equine Fertility Breakthrough: Felix™ Device Positioned for Global Market Launch
We’re excited to announce that we’ve embarked on a three-year equine fertility study aimed at establishing our Felix™…
Memphasys Q&A: On a mission to fine tune animal fertility.
Optimised animal breeding success can only be a great thing for our community, which is why Memphasys is committed to…
The Growing Challenge of Male Infertility in India: New Solutions on the Horizon
Male infertility has emerged as a significant health issue in India, accounting for nearly 40-50% of all infertility…
Memphasys: Embracing a contemporary work environment and keeping costs in check with a new office move.
Memphasys office relocation and strategic management change to a more efficient space have significantly reduced costs.
Over $1M in Funding Secured to Accelerate Innovations in Reproductive Biotechnology
We are excited to announce significant financial developments that promise to propel our innovative projects forward.…
Pioneering Advances in Assisted Reproductive Technology
We are continuing to make significant strides in the field of assisted reproductive technology (ART). With the recent…
Social Change: Rethinking Parenthood, Work, and Marriage in a Changing World
As fertility rates fall in advanced industrialised nations and our populations become smaller and older, it is crucial…
Memphasys Maintains ISO 13485 Certification: A New Milestone in Quality and Innovation
We continue to maintain our ISO 13485 certification, a testament to our commitment to the highest standards of quality…
Countering Oxidative Stress: The Crucial Impact on Male Reproduction and Infertility Solutions
Spermatozoa are very vulnerable to oxidative stress largely because their intrinsic lack of cytoplasm places…
We are thrilled to welcome Dr. David Ali as Permanent CEO
We’re excited to announce that Dr. David Ali, who has been serving as our Acting CEO and Executive Director, has been…